Literature DB >> 12212833

N-acetylcysteine as salvage therapy in cisplatin nephrotoxicity.

Sabeeha Nisar1, Donald A Feinfeld.   

Abstract

N-acetylcysteine (NAC) repletes intracellular stores of reduced glutathione and may be a scavenger of oxygen free radicals. We report a 52-year-old female who developed acute renal insufficiency after administration of one dose of 150 mg of cisplatin for treatment of squamous cell cancer of the esophagus. Her blood urea nitrogen and creatinine rose from 12 and 0.7 mg/dL, respectively, to 24 and 1.8 mg/dL on day 5 after cisplatin. On that day the patient was begun on NAC, starting with a loading dose of 140-mg/kg-body weight followed by 70mg/kg every 4h for 4 days. Two days after starting NAC her renal function began to improve, and although she failed to complete a full course of the drug, by day 10 her serum creatinine had fallen to 0.8 mg/dL. A previous report showed that N-acetylcysteine might reverse cisplatin-induced renal toxicity. Our case supports this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12212833     DOI: 10.1081/jdi-120006780

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  13 in total

1.  Oleuropein Ameliorates Cisplatin-induced Hematological Damages Via Restraining Oxidative Stress and DNA Injury.

Authors:  Fatime Geyikoğlu; Suat Çolak; Hasan Türkez; Murat Bakır; Kübra Koç; Mir Khalil Hosseinigouzdagani; Salim Çeriğ; Merve Sönmez
Journal:  Indian J Hematol Blood Transfus       Date:  2016-08-16       Impact factor: 0.900

2.  Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models.

Authors:  D Thomas Dickey; Leslie L Muldoon; Nancy D Doolittle; Darryl R Peterson; Dale F Kraemer; Edward A Neuwelt
Journal:  Cancer Chemother Pharmacol       Date:  2007-10-02       Impact factor: 3.333

Review 3.  Cisplatin overdose: toxicities and management.

Authors:  Roger Y Tsang; Turki Al-Fayea; Heather-Jane Au
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 4.  Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies.

Authors:  Gi-Su Oh; Hyung-Jin Kim; AiHua Shen; Su Bin Lee; Dipendra Khadka; Arpana Pandit; Hong-Seob So
Journal:  Electrolyte Blood Press       Date:  2014-12-31

5.  Effects of pretreatment with single-dose or intermittent oxygen on Cisplatin-induced nephrotoxicity in rats.

Authors:  Bahram Rasoulian; Ayat Kaeidi; Soheila Pourkhodadad; Omid Dezfoulian; Maryam Rezaei; Hannaneh Wahhabaghai; Masoud Alirezaei
Journal:  Nephrourol Mon       Date:  2014-09-05

Review 6.  Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Fatemeh Eshraghi Jazi; Bahar Mazaheri; Maryam Moeini; Tahereh Safari; Fariba Azarkish; Fatemeh Moslemi; Maryam Maleki; Alireza Rezaei; Shadan Saberi; Aghdas Dehghani; Maryam Malek; Azam Mansouri; Marzieh Ghasemi; Farzaneh Zeinali; Zohreh Zamani; Mitra Navidi; Sima Jilanchi; Soheyla Shirdavani; Farzaneh Ashrafi
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

7.  Effects of Fennel Essential Oil on Cisplatin-induced Nephrotoxicity in Ovariectomized Rats.

Authors:  Safoora Mazaheri; Mehdi Nematbakhsh; Mehrnoosh Bahadorani; Zahra Pezeshki; Ardeshir Talebi; Ali-Reza Ghannadi; Farzaneh Ashrafi
Journal:  Toxicol Int       Date:  2013-05

8.  Sex-Related Difference in Nitric Oxide Metabolites Levels after Nephroprotectant Supplementation Administration against Cisplatin-Induced Nephrotoxicity in Wistar Rat Model: The Role of Vitamin E, Erythropoietin, or N-Acetylcysteine.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki
Journal:  ISRN Nephrol       Date:  2013-03-11

9.  Nephroprotective effect of estrogen and progesterone combination on cisplatin-induced nephrotoxicity in ovariectomized female rats.

Authors:  M Ghasemi; M Nematbakhsh; Z Pezeshki; N Soltani; M Moeini; A Talebi
Journal:  Indian J Nephrol       Date:  2016 May-Jun

Review 10.  Cisplatin-induced renal toxicity in elderly people.

Authors:  ZhiYu Duan; GuangYan Cai; JiJun Li; XiangMei Chen
Journal:  Ther Adv Med Oncol       Date:  2020-05-18       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.